Close X
Attorney Spotlight

How does Jordana Nelson's prior experience as a general counsel inform her work with firm clients? Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

The M&A Advisor Winner 2017The M&A Advisor announced the winners of the 16th Annual M&A Advisor Awards on Monday, November 13 at the 2017 M&A Advisor Awards. Bass, Berry & Sims was named a winner in the two categories related to the following deals:

M&A Deal of the Year (from $1B-$5B) – Acquisition of CLARCOR Inc. by Parker Hannifin Corporation

Corporate/Strategic Deal of the Year (over $1B) – Acquisition of BNC Bancorp by Pinnacle Financial Partners

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Regulation A+

It seems that lately there has been a noticeable uptick in Regulation A+ activity, including several recent Reg A+ securities offerings where the stock now successfully trades on national exchanges. In light of this activity, we have published a set of FAQs about Regulation A+ securities offerings to help companies better understand this "mini-IPO" offering process, as well as pros and cons compared to a traditional underwritten IPO.

Read now

Janelle Waack Provides Insight on Supreme Court Review of PTAB IPR Decision in Cuozzo and Its Impact on Pharmaceutical Patents

Modern Healthcare

Media Mentions

April 25, 2016

Bass, Berry & Sims attorney Janelle Waack provided comment for an article in Modern Healthcare regarding Cuozzo Speed Technologies v. Lee, which is being heard by the U.S. Supreme Court on April 25, 2016. The outcome of this case could change the claim construction standard used in resolving patent challenges at the USPTO Patent Trial and Appeal Board. "It's remarkable because you're changing the standard of a fundamental issue in patent disputes," Janelle said of the case. "It would tend to tilt the playing field in favor of the patent owners," Janelle said.

The full article, "Supreme Court Patent Case has Major Implications for Drugmakers," was published by Modern Healthcare on April 22, 2016, and is available online.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.